| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000038909 |
| Receipt No. | R000044327 |
| Scientific Title | Effect of hair growth KB001 |
| Date of disclosure of the study information | 2019/12/31 |
| Last modified on | 2020/12/17 (Ver. 2) |
| Basic information | ||
| Public title | Effect of hair growth KB001 | |
| Acronym | Effect of hair growth KB001 | |
| Scientific Title | Effect of hair growth KB001 | |
| Scientific Title:Acronym | Effect of hair growth KB001 | |
| Region |
|
|
| Condition | ||
| Condition | Androgenic alopecia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of hair growth KB001 |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall improvement level |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Apply hair growth KB001 for 24 weeks. | |
| Interventions/Control_2 | Apply positive control for 24 weeks. | |
| Interventions/Control_3 | Apply placebo for 24 weeks. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1 Japanese males aged 20 to 60 years old
2 Subjects who are concerned about Androgenic alopecia |
|||
| Key exclusion criteria | 1 Subjects who have other disease except for Androgenic alopecia
2 Subjects who allergy history on scalp |
|||
| Target sample size | 90 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shiba Palace Clinic | ||||||
| Division name | Chair | ||||||
| Zip code | 105-0013 | ||||||
| Address | DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN | ||||||
| TEL | 03-5408-1590 | ||||||
| jimukyoku@mail.souken-r.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | SOUKEN Co., Ltd | ||||||
| Division name | Management Division | ||||||
| Zip code | 105-0013 | ||||||
| Address | DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN | ||||||
| TEL | 03-5408-1555 | ||||||
| Homepage URL | |||||||
| k_masuda@mail.souken-r.com | |||||||
| Sponsor | |
| Institute | Shiba Palace Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kobayashi Pharmaceutical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shiba Palace Clinic Ethics Review Committee |
| Address | DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN |
| Tel | 03-5408-1599 |
| shiba_palace@s-palace-clinic.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 90 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000044327 |